Glomerulopathies –IgA nephropathy IgA nephropathy - Pathogenesis.
1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction,...
-
Upload
buddy-sutton -
Category
Documents
-
view
220 -
download
0
Transcript of 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction,...
![Page 1: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/1.jpg)
1
![Page 2: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/2.jpg)
2
DIABETIC NEPHROPATHY
Dr. Shahrzad Shahidi
![Page 3: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/3.jpg)
3
CLASSIFICATION
1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency)
2. Type 2 (due to a progressive insulin secretory defect on the background of insulin resistance)
3. Gestational DM (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes)
4. Specific types of diabetes due to other causes, e.g:
Monogenic diabetes syndromes(such as MODY)
Diseases of the exocrine pancreas (such as cystic fibrosis)
Drug- or chemical-induced diabetes
![Page 4: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/4.jpg)
4
Testing to Assess Risk for Future DM in Asymptomatic People
1. Adults of any age who are overweight or obese (BMI ≥25) & who have ≥ 1 additional risk factors for DM.
2. For all patients, particularly those who are overweight or obese, testing should begin at age 45 years.
3. Testing to detect prediabetes should be considered in children & adolescents who are overweight or obese & who have ≥ 2 additional risk factors for DM.
![Page 5: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/5.jpg)
5
Risk Factors Physical inactivity First-degree relative with DM High-risk race/ethnicity Women who delivered a baby weighing>4 kg
or were diagnosed with GDM Hypertension HDL cholesterol <35 mg/dL &/or a TG >250 mg/dL
Women with polycystic ovary syndrome A1C ≥ 5.7%, IGT, or IFG on previous testing Other clinical conditions associated with
insulin resistance (e.g., severe obesity, acanthosis nigricans)
History of CVD
![Page 6: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/6.jpg)
6
Testing to Assess Risk for Future DM in Asymptomatic People
In patients with prediabetes, identify &, if appropriate, treat other cardiovascular disease (CVD) risk factors.
If tests are normal, repeat testing carried out at a minimum of 3 year intervals is reasonable.
To test for prediabetes, the A1C, FPG, & 2-h PG after 75-g OGTT are appropriate. Then yearly
![Page 7: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/7.jpg)
7
ADA Diagnostic Criteria:Clinical Practice Recommendations 2015
In the absence of unequivocal hyperglycemia, criteria 1, 2, and 4 should be confirmed by repeat testing.
Parameter
Normal
Diabetes
Pre-diabetes
Method
1 Fasting Plasma Glucose (mg/dl)
<100 ≥126 100–125 No caloric intake for at least 8 h
2 2-h plasma glucose on OGTT (mg/dl)
<140 ≥200 140–199 WHO method: 75 g glucose load
3 Random plasma glucose (mg/dl)
<140 ≥200 - with classic symptoms of hyperglycemia or crisis
4 Hb A1C (%) <5.7 ≥6.5 5.7 – 6.4 NGSP certified method standardized to the DCCT assay
![Page 8: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/8.jpg)
8
Criteria for the Diagnosis of Diabetes
HbA1C ≥ 6.5% (fasting not required)
OR FPG ≥ 126 mg/dL
Fasting is defined as no caloric intake for at least 8 h
OR 2-h PG ≥ 200 mg/dL during an
OGTTOR
A random plasma glucose ≥ 200 mg/dL
![Page 9: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/9.jpg)
9
Components of the Comprehensive Diabetes Evaluation
Laboratory evaluation: A1C, if results not available within past 3 ms If not performed/available within past year
Fasting lipid profile, including total, LDL, & HDL cholesterol & TG, as needed
Liver function tests Test for urine albumin excretion with spot urine
albumin-to-cr ratio Serum cr & calculated GFR TSH in type 1 DM, dyslipidemia, or women > 50 ys
![Page 10: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/10.jpg)
10
Referrals
1. Eye care professional for annual dilated eye exam
2. Family planning for women of reproductive age
3. Registered dietitian for medical nutrition therapy
4. DSME/DSMS
5. Dentist for comprehensive periodontal examination
6. Mental health professional, if needed
![Page 11: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/11.jpg)
11
Mean Glucose Levels for Specified A1C levels
HbA1C (%)
Mean Plasma Glucose (mg/dL)
6 1267 1548 1839 214
10 24011 26912 298
![Page 12: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/12.jpg)
12
Glycemic Recommendations for Nonpregnant Adults with DM
A1C < 7%
Preprandial capillary plasma glucose
80–130 mg/dL
Peak postprandial capillary plasma glucose†
< 180 mg/dL
![Page 13: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/13.jpg)
13
Goals Should be Individualized Based on:
Duration of diabetes Age/life expectancy Comorbid conditions known CVD or advanced microvascular
complications Hypoglycemia unawareness Individual patient considerations
![Page 14: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/14.jpg)
14
Diabetic Nephropathy
Diabetic kidney disease occurs in 20–40% of patients with diabetes & is the leading cause of ESRD.
Persistent increased albuminuria in the range of UACR 30–299 mg/g is an early indicator of diabetic kidney disease in type 1 & a marker for development of diabetic kidney disease in type 2 .
![Page 15: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/15.jpg)
15
Diabetic Nephropathy
Diabetic kidney disease occurs in 20–40% of patients with diabetes & is the leading cause of ESRD.
Persistent increased albuminuria in the range of UACR 30–299 mg/g is an early indicator of diabetic kidney disease in type 1 & a marker for development of diabetic kidney disease in type 2 .
![Page 16: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/16.jpg)
Diabetic Nephropathy
Incidence of ESRD Resulting from Primary
Diseases (1998)
43%
23%
12%
3%
19%
Diabetes
Hypertension
Glomerulonephritis
Cystic Kidney
Other Causes
h Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.
h The 5-year mortality rate for a dialysis patient with diabetic nephropathy is 93%.
h Dialysis for one patient costs over $50,000 annually.
![Page 17: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/17.jpg)
17
Diabetic Nephropathy
Definition or Criteria: Presence of persistent proteinuria in sterile urine of diabetic patients with concomitant diabetic retinopathy & HTN.
![Page 18: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/18.jpg)
18
![Page 19: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/19.jpg)
19
Stages of Diabetic Nephropathy
020406080
100120140160180
0 5 10 15 20 25 30
Duration of Diabetes
GFR
III
III
IV
V
![Page 20: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/20.jpg)
20
Recommendations to Reduce the Risk or Slow the Progression of DN
Optimize glucose control
Optimize BP control (< 140/90)
![Page 21: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/21.jpg)
21
Recommendations to Reduce the Risk or Slow the Progression of DN
Screening at least once a year, quantitatively assess urinary albumin (e.g., UACR) & eGFR in patients: Type 1 diabetes duration of ≥ 5 years All patients with type 2 diabetes
![Page 22: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/22.jpg)
22
Diabetic Nephropathy: Treatment
An ACEI or ARB is not recommended for the primary prevention of DN in patients with diabetes who have normal BP & normal UACR (<30 mg/g).
Either an ACEI or ARB is suggested for the treatment of the nonpregnant patient with modestly elevated urinary albumin excretion (30–299 mg/d) & is recommended for those with urinary albumin excretion < 300 mg/d.
When ACEIs, ARBs, or diuretics are used, monitor serum Cr & K levels.
Continued monitoring of UACR in patients with albuminuria is reasonable to assess progression of DN.
When eGFR is < 60 mL/min/1.73 m2, evaluate & manage potential complications of CKD.
![Page 23: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/23.jpg)
23
Diabetic Nephropathy: Treatment
Referral to a Nephrologist when: There is uncertainty about the
etiology of kidney disease Difficult management issues Advanced kidney disease
![Page 24: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/24.jpg)
24
Diabetic Nephropathy: Treatment
Nutrition: For people with DN, reducing the
amount of dietary pr below the recommended daily allowance of 0.8 g/kg/day (based on ideal body weight) is not recommended because it does not alter glycemic measures, cardiovascular risk measures, or the course of GFR decline.
![Page 25: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/25.jpg)
25
Management of CKD in DM
GFR (mL/min/1.73 m2) Recommended management
All patients Yearly measurement of Cr, urinary albumin excretion, K
![Page 26: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/26.jpg)
26
Management of CKD in DM
GFR (mL/min/1.73 m2) Recommended management
45–60 • Referral to a nephrologist if possibility for nondiabetic kidney disease
• Consider the need for dose adjustment of medications
• Monitor eGFR every 6 months
• Monitor electrolytes, HCO3, Hb, Ca, P, PTH at least yearly
• Assure vitamin D sufficiency
• Consider bone density testing
• Referral for dietary counseling
![Page 27: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/27.jpg)
27
Management of CKD in DM
GFR (mL/min/1.73 m2) Recommended management
30–44 • Monitor eGFR every 3 ms• Monitor electrolytes, HCO3,
Ca, P, PTH, Hb, Alb, weight every 3–6 ms
• Consider the need for dose adjustment of medications
< 30 Referral to a nephrologist
![Page 28: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/28.jpg)
28
Q. Which features are typical of DN at presentation ?
Haematuria Small scarred kidneys Progress to ESKD in <2yrs Associated retinopathy β-blockers better than ACE-I Rx
![Page 29: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/29.jpg)
29
Q. Which features are typical of DN at presentation ?
Haematuria NO Small scarred kidneys NO Progress to ESKD in <2yrs NO Associated retinopathy YES β-blockers better than ACE-I Rx NO
![Page 30: 1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.](https://reader030.fdocuments.net/reader030/viewer/2022032801/56649dd95503460f94acee89/html5/thumbnails/30.jpg)
30